Cargando…

Thromboelastography for the monitoring of the antithrombotic effect of low-molecular-weight heparin after major orthopedic surgery

OBJECTIVE: Low-molecular-weight heparins (LMWHs) are commonly used to prevent and manage postoperative thromboembolism. In general, monitoring of anticoagulant activity by anti-Xa testing is not done properly. Thromboelastography (TEG) evaluates the viscoelastic properties of blood during coagulatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tekkesin, Nilgün, Tekkesin, Mustafa, Kaso, Güzin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2016
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336946/ https://www.ncbi.nlm.nih.gov/pubmed/26574762 http://dx.doi.org/10.5152/akd.2014.5723

Ejemplares similares

Cartridge-Based Thromboelastography Can Be Used to Monitor and Quantify the Activity of Unfractionated and Low-Molecular-Weight Heparins
por: Dias, João D., et al.
Publicado: (2019)

Impaired fasting glucose is associated with increased perioperative cardiovascular event rates in patients undergoing major non-cardiothoracic surgery
por: Biteker, Murat, et al.
Publicado: (2011)

Application of basic and composite thrombelastography parameters in monitoring of the antithrombotic effect of the low molecular weight heparin dalteparin: an in vivo study
por: Artang, Ramin, et al.
Publicado: (2009)

Thromboelastography for the Prevention of Perioperative Venous Thromboembolism in Orthopedics
por: Fan, Dejing, et al.
Publicado: (2022)

Evaluation of hemostatic changes using thromboelastography after crystalloid or colloid fluid administration during major orthopedic surgery
por: Topçu, I., et al.
Publicado: (2012)

Monitoring of Hypercoagulability by Thromboelastography in Bariatric Surgery
por: Kupcinskiene, Kristina, et al.
Publicado: (2017)

Fondaparinux sodium and low molecular weight heparin for venous thromboembolism prophylaxis in Chinese patients with major orthopedic surgery or trauma: a real-world study
por: Fu, Donglin, et al.
Publicado: (2022)

Postoperative management of antithrombotic medication in microvascular head and neck reconstruction: a comparative analysis of unfractionated and low-molecular-weight heparin
por: Sievert, Matti, et al.
Publicado: (2020)

Comparison of uninterrupted warfarin and bridging therapy using low-molecular weight heparin with respect to the severity of bleeding after dental extractions in patients with prosthetic valves
por: Erden, İsmail, et al.
Publicado: (2016)

Comparison of low-molecular-weight heparins in thromboprophylaxis of major orthopaedic surgery – randomized, prospective pilot study
por: Biławicz, Jan, et al.
Publicado: (2020)

Analysis of the Prevalence and Quantification of Viral Load of Different Human Papillomavirus Types in Turkish Women Population
por: Tekkesın, Nilgun, et al.
Publicado: (2022)

Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery
por: Wurnig, Christian, et al.
Publicado: (2015)

Rotational thromboelastography in a patient with heparin-induced thrombocytopenia: a case report
por: Silva, EA, et al.
Publicado: (2007)

Monitoring of treatment with low molecular weight heparins using viscoelastic devices
por: Schött, U, et al.
Publicado: (2014)

Gene Polymorphisms of Adducin GLY460TRP, ACE I/D, and AGT M235T in Pediatric Hypertension Patients
por: Kaplan, İbrahim, et al.
Publicado: (2014)

Achieving higher efficacy without compromising safety with factor XI inhibitors versus low molecular weight heparin for the prevention of venous thromboembolism in major orthopedic surgery—Systematic review and meta‐analysis
por: Presume, João, et al.
Publicado: (2022)

Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014)

Preoperative Low-Molecular-Weight Heparin Prophylaxis Associated with Increased Heparin Resistance Frequency in On-Pump Coronary Artery Bypass Graft Surgery
por: Saydam, Onur, et al.
Publicado: (2019)

Heparin/low molecular weight heparins: Thrombocytopenia: 7 case reports
Publicado: (2021)

Comparison Between Non–vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism
por: Chen, Dong-Yi, et al.
Publicado: (2021)

The first six-month clinical outcomes and risk factors associated with high on-treatment platelet reactivity of clopidogrel in patients undergoing coronary interventions
por: Tekkeşin, Ahmet İlker, et al.
Publicado: (2016)

Arterial indications for the low molecular weight heparins
por: Ageno, Walter, et al.
Publicado: (2001)

Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels
por: Bengalorkar, Girish M., et al.
Publicado: (2011)

Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin
por: Chen, Jianle, et al.
Publicado: (2019)

Odontogenic tumors: where are we in 2017 ?
por: Wright, John M., et al.
Publicado: (2017)

The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5(th)) Edition
por: Soluk-Tekkesin, Merva, et al.
Publicado: (2022)

Preventing Thrombohemorrhagic Complications of Heparinized COVID-19 Patients Using Adjunctive Thromboelastography: A Retrospective Study
por: Bunch, Connor M., et al.
Publicado: (2021)

CRT-D or CRT-P in CRT-indicated patients?
por: Kaya, Adnan, et al.
Publicado: (2017)

Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration
por: Xu, Lengnan, et al.
Publicado: (2023)

A meta-analysis of bridging anticoagulation between low molecular weight heparin and heparin
por: Tao, Ende, et al.
Publicado: (2020)

The Triglyceride-Glucose Index Can Predict Long-Term Major Adverse Cardiovascular Events in Turkish Patients With High Cardiovascular Risk
por: Hayıroğlu, Mert İlker, et al.
Publicado: (2022)

Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID-19 Infection
por: Magnani, Harry N.
Publicado: (2021)

Low-molecular-weight heparins in the treatment of venous thromboembolism
por: Ageno , Walter, et al.
Publicado: (2000)

The Effect of Low Molecular Weight Heparins on Fracture Healing
por: Kapetanakis, Stylianos, et al.
Publicado: (2015)

Low-molecular weight heparin infusion as anticoagulation for haemodialysis
por: Wong, Steve Siu-Man, et al.
Publicado: (2016)

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
por: Perna, Alessandra F., et al.
Publicado: (2020)

Management of intentional overdose of low-molecular-weight heparin
por: Lu, Clara, et al.
Publicado: (2022)

Monitoring of Antithrombotic Therapy
por: Yamazaki, Masako
Publicado: (2020)

Symptomatic Bradycardia Caused By Premature Atrial Contractions Originating From Right Atrial Appendage
por: Alper, AT, et al.
Publicado: (2013)

Cyclooxygenase-2 and Ki67 Expression in Oral Leukoplakia: a Clinicopathological Study
por: Sinanoglu, Alper, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hr5328r04ojtct144ul6qc17on